Radiotherapy (RT) is an important treatment modality for cancer patients. Approximately 50% of all patients receive RT during the course their illness. A great potential to improve results involves combination with other methods. The and cytotoxic chemotherapy a clinically well-established documen­ted method survival. Integration targeted therapy may provide therapeutic benefit by exploiting bi...

abstract background and aims: the number of new cancer cases with considerable mortality is increasing worldwide. since the inability of current therapies in treatment of patients and prevention the progress of tumors with fewer side effects, implementation of new methods is needed. gene therapy has widespread systemic cytotoxic effects against tumor cells. rotavirus nsp4 has been shown to elic...

Proteases are often overexpressed in tumor cells and/or the stromal compartment and can thus be exploited in tumor therapy to activate cytotoxic prodrugs as, for example, in cytolytic fusion proteins, and for tumor imaging. Specifically, we discuss cathepsin B-activated prodrug conjugates, antibody-directed prodrug therapy, protease-activated peptide-thapsigargin conjugates, protease-activated ...

The cytotoxic T lymphocyte (CTL, Tc) is a type of T lymphocyte/ white blood cell involved in the host’s cell-mediated immune response against cancerous cells, abnormal cells and cells infected with viruses. Signals from infected cells or cancer cells lead to the release of cytotoxins: perforin, granzymes, and granulysin by the TC cells. The activation of CTLs is mediated by the interaction of v...

There is a number of drugs demonstrating specific activity towards hereditary cancers. For example, tumors in BRCA1/2 mutation carriers usually arise via somatic inactivation of the remaining BRCA allele, which makes them particularly sensitive to platinum-based drugs, PARP inhibitors (PARPi), mitomycin C, liposomal doxorubicin, etc. There are several molecular assays for BRCA-ness, which permi...

in the recent years, targeted therapy of the neoplastic diseases is a current strategy used by oncologists. hence, design and discovery of novel targeted anticancer therapeutics is an interesting topic in the current research of medicinal chemistry. a new series of 1,3,4-thiadiazole derivatives were prepared and their anticancer activity was assessed against pc3, sknmc and ht29 cell lines by ap...

Colorectal cancer is a relatively common tumor with incidence that has been increasing during recent decades. Despite the rapid advances in treatment of colorectal cancer, the best way to combine and sequence all available drugs to optimize treatment is not yet established. The majority of cytotoxic drugs used in therapy of colorectal cancer have a dose related effect and narrow therapeutic ind...

Esophageal squamous cell carcinoma is an aggressive malignancy with histologic variability depending on where in the world it diagnosed, most of these cancers occurring China and other parts Asia. Previous studies cytotoxic chemotherapy combinations led to a plateau median overall survival approximately 10 12 months, as well need for more effective treatment options. Cytotoxic served control ar...

Therapy related myeloid malignancies are an increasingly recognized treat complication in patients undergoing therapy for multiple myeloma. The main predisposing factors are the alkylating agents, topoisomerase II inhibitors and radiotherapy, but recently questions have been raised regarding the immunomodulatory agent lenal antimyeloma agents in the context of therapy related myeloid malignanci...